FMP
Pressure BioSciences, Inc.
PBIO
PNK
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.
0.0131 USD
0.0004 (3.05%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
318.79M
425.49M
595.34M
766.89M
975.18M
1.29B
1.71B
2.26B
2.99B
3.96B
21.19M
647k
-43.23M
75.94M
154.29M
65.21M
86.3M
114.2M
151.14M
200.02M
-134.57M
-322.1M
-230.07M
-239.09M
-
-484.57M
-641.28M
-848.68M
-1.12B
-1.49B
-113.38M
-321.45M
-273.3M
-163.15M
154.29M
-419.36M
-554.99M
-734.47M
-972.01M
-1.29B
10.89
10.89
10.89
10.89
10.89
-378.18M
-451.34M
-538.65M
-642.85M
-767.21M
-2.78B